VativoRx to be featured on PBS stations in US

VativoRx to be featured on PBS stations in US

Recently, a crew affiliated with the Public Broadcasting System (PBS) spent the day with the VativoRx team at our headquarters in Miami.

The goal: shoot a segment about our efforts to improve the quality of pharmacy benefit management in the United States. We talked about how our twin goals of accessibility and affordability benefit plan sponsors, their employees and their employees’ families. You can see the video below:

We’ll have more details on where and when the segment will play as we get closer to the premiere date in April, 2022.

Biosimilars — Similar But Not Identical

You may have never heard of biosimilar drugs and that’s probably because they are not commonly prescribed in the United States even though they have been around for over 20 years. So, what are biosimilar drugs? A biosimilar drug is no different in terms of safety and effectiveness than a biologic product, also known as a reference product, and while highly similar it is not identical.

Read More »

Lower Cost Prescription Drugs from Canada, Is It Legal?

In the early 2000s, the FDA set up guidelines in the Regulatory Procedures Manual (RPM) that permitted prescription drugs to be imported from other countries if the patient met very strict guidelines. Just stating that the patient needed the drug due to cost savings was not a justification to obtain the drug.

Read More »